← SynDRA
TAZOBACTAM
SynDRA canonical compound SYN0000017 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | beta lactamase inhibitor |
| Indication | pneumonia |
| Disease area | infectious disease |
All known targets
- BlaGIL-1
- blaSHV-72
- penP
- penB1
- oxa-63
- imiA
- blaZ
- blaUOE-1
- blaTEM-125
- blaTEM-1
- blaSCO-1
- Stap-coc blaZ
Mechanisms of action (all sources)
- beta lactamase inhibitor
- Inhibitor
- bla; blaT-3; blaT-4; INHIBITOR
Drug classes
- beta Lactamase Inhibitors
- Anti-Bacterial Agents
- Anti-Infective Agents
- beta-Lactamase Inhibitors
- Enzyme Inhibitors
- beta Lactamase Inhibitor
ATC classes
- J01C · BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Cross-references
Synonyms
- tazobactam sodium
- YTR 830
- CL 298,741
- CL-298741
- NSC-759887
- YTR-830H
- TAZ
- CL298741
- YTR830H
- Piprataz (TN)
- Tazobactam (JAN/USAN/INN)
- (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4
- (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
- Tazobactamum
- YTR 830H
- CHEBI:9421
- SE10G96M8W
- NSC 759887
- CXA201
- YTR830
- RefChem:891206
- DTXCID003634
- J01CG02
- Tazobactam acid
- MFCD00867002
- Tazobactam;Tazobactan acid
- YTR 830 H
- CL-298741;YTR-830H
- SR-01000872598
- Tazobactamum [INN-Latin]
- C10H12N4O5S
- UNII-SE10G96M8W
- CCRIS 2203
- Tazobactam [USAN:USP:INN:BAN]
- Tazobactam (Standard)
- BRN 4787943
- TAZOBACTAM [MI]
- TAZOBACTAM [INN]
Reported adverse events
- Alanine aminotransferase increased
- Headache
- Hypotension
- Insomnia
- Nausea
- Phlebitis
- Rash
- Abdominal pain
- Alanine aminotransferase
- Arthralgia
- Aspartate aminotransferase
- Aspartate aminotransferase increased
Look up TAZOBACTAM in the interactive SynDRA portal →